Lundquist Institute for Medical Innovation at Harbor-UCLA Medical Center


The Lundquist Institute is an engine of innovation with a global reach and a 70-year reputation of improving and saving lives. It focuses on cutting-edge biomedical research, education, and community outreach efforts, aiming to address significant health challenges and enhance patient outcomes.

Industries

biotechnology
medical
non-profit

Nr. of Employees

Very Large (1000+)

Lundquist Institute for Medical Innovation at Harbor-UCLA Medical Center


Products

Candida auris multi-antigen vaccine candidate

A multi-antigen vaccine candidate targeting fungal cell-surface proteins, demonstrated to induce neutralizing antibody and T-cell responses and to protect mice in preclinical infection models.

Shared stem cell resource (hPSC disease-modeling core)

A funded shared-resource core offering hPSC-derived cell types, protocols and training to support disease modeling and regenerative research across partner institutions.

Wearable multiplex biosensor prototype

Research-stage wearable sensor system designed to monitor multiple physiologic signals for early detection of exacerbation risk in chronic respiratory disease.


Services

Protocol development, trial execution, participant monitoring and data collection for investigator-initiated and sponsored clinical trials.

A shared-resource laboratory offering hPSC-derived cell-type generation, training, and access to stem cell disease-modeling workflows for partner investigators and trainees.

Provision of incubator laboratory space and support services to early-stage biotech companies and translational teams.

Clinical imaging services including cardiac CT screening and quantitative imaging workflows supporting research and community access programs.

Management of intellectual property and facilitation of licensing agreements for patented research technologies.

Public-facing WIC program offering nutrition education and breastfeeding support to low-income women, infants and children.

Expertise Areas

  • Clinical trial management
  • Vaccine development and immunotherapy
  • Stem cell disease modeling (hPSC)
  • Infectious disease research
  • Show More (6)

Key Technologies

  • Human pluripotent stem cell (hPSC) disease modeling
  • Antigen design and vaccine formulation
  • Biologics/antigen manufacturing
  • Wearable multiplex biosensors
  • Show More (5)

News & Updates

Join us at Legends 2024 as we celebrate over 70 years of groundbreaking biomedical innovation at The Lundquist Institute and honor our 2024 Legends.

Dr. Shakti Singh has been awarded a five-year NIH grant for groundbreaking research on Candida auris.

The Lundquist Institute's WIC Program received the USDA 2024 WIC Breastfeeding Gold Award of Excellence for outstanding achievement in supporting and promoting breastfeeding.

The Lundquist Institute's WIC Program was recognized for its exemplary efforts in breastfeeding promotion and support.

Dr. Shakti Singh received a prestigious K01 grant to support his research on Candida auris.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.